aluates Reports

$ 0.0

Automative

Global Oral Erectile Dysfunction Therapeutic Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-14S13824

Global Oral Erectile Dysfunction Therapeutic Market Research Report 2023

BUY CHAPTERS

Global Oral Erectile Dysfunction Therapeutic Market Research Report 2025

Code: QYRE-Auto-14S13824

Report

July 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

Pfizer Inc

Bayer

Teva Pharma

S.K. Chemicals

Seoul Pharma

CSBIO

Oral Erectile Dysfunction Therapeutic Market Size

The global market for Oral Erectile Dysfunction Therapeutic was valued at US$ 1109 million in the year 2024 and is projected to reach a revised size of US$ 1658 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Oral Erectile Dysfunction Therapeutic Market

Erectile dysfunction (ED) is the type of sexual dysfunction when a man cannot maintain a firm erection of the penis or coitus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Erectile Dysfunction Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Erectile Dysfunction Therapeutic.

The Oral Erectile Dysfunction Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Erectile Dysfunction Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Erectile Dysfunction Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Erectile Dysfunction Therapeutic Market Report

Report Metric	Details
Report Name	Oral Erectile Dysfunction Therapeutic Market
Accounted market size in year	US$ 1109 million
Forecasted market size in 2031	US$ 1658 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Protein Hormones Other
Segment by Application	Age <20 Age 20-30 Age 31-40 Age 41-50 Age >50
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Pfizer, Bayer, Teva Pharma, S.K. Chemicals, Seoul Pharma, CSBIO.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Erectile Dysfunction Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Erectile Dysfunction Therapeutic Market growing?

Ans: The Oral Erectile Dysfunction Therapeutic Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Oral Erectile Dysfunction Therapeutic Market size in 2031?

Ans: The Oral Erectile Dysfunction Therapeutic Market size in 2031 will be US$ 1658 million.

Who are the main players in the Oral Erectile Dysfunction Therapeutic Market report?

Ans: The main players in the Oral Erectile Dysfunction Therapeutic Market are Eli Lilly, Pfizer, Bayer, Teva Pharma, S.K. Chemicals, Seoul Pharma, CSBIO.

What are the Application segmentation covered in the Oral Erectile Dysfunction Therapeutic Market report?

Ans: The Applications covered in the Oral Erectile Dysfunction Therapeutic Market report are Age <20, Age 20-30, Age 31-40, Age 41-50, Age >50

What are the Type segmentation covered in the Oral Erectile Dysfunction Therapeutic Market report?

Ans: The Types covered in the Oral Erectile Dysfunction Therapeutic Market report are Protein, Hormones, Other

Recommended Reports

Genitourinary Treatments

Sexual Dysfunction

Oral Medicine Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Protein

1.2.3 Hormones

1.2.4 Other

1.3 Market by Application

1.3.1 Global Oral Erectile Dysfunction Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Age <20

1.3.3 Age 20-30

1.3.4 Age 31-40

1.3.5 Age 41-50

1.3.6 Age >50

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Erectile Dysfunction Therapeutic Market Perspective (2020-2031)

2.2 Global Oral Erectile Dysfunction Therapeutic Growth Trends by Region

2.2.1 Global Oral Erectile Dysfunction Therapeutic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Erectile Dysfunction Therapeutic Historic Market Size by Region (2020-2025)

2.2.3 Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Region (2026-2031)

2.3 Oral Erectile Dysfunction Therapeutic Market Dynamics

2.3.1 Oral Erectile Dysfunction Therapeutic Industry Trends

2.3.2 Oral Erectile Dysfunction Therapeutic Market Drivers

2.3.3 Oral Erectile Dysfunction Therapeutic Market Challenges

2.3.4 Oral Erectile Dysfunction Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Erectile Dysfunction Therapeutic Players by Revenue

3.1.1 Global Top Oral Erectile Dysfunction Therapeutic Players by Revenue (2020-2025)

3.1.2 Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Players (2020-2025)

3.2 Global Oral Erectile Dysfunction Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Erectile Dysfunction Therapeutic Revenue

3.4 Global Oral Erectile Dysfunction Therapeutic Market Concentration Ratio

3.4.1 Global Oral Erectile Dysfunction Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Erectile Dysfunction Therapeutic Revenue in 2024

3.5 Global Key Players of Oral Erectile Dysfunction Therapeutic Head office and Area Served

3.6 Global Key Players of Oral Erectile Dysfunction Therapeutic, Product and Application

3.7 Global Key Players of Oral Erectile Dysfunction Therapeutic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Erectile Dysfunction Therapeutic Breakdown Data by Type

4.1 Global Oral Erectile Dysfunction Therapeutic Historic Market Size by Type (2020-2025)

4.2 Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Type (2026-2031)

5 Oral Erectile Dysfunction Therapeutic Breakdown Data by Application

5.1 Global Oral Erectile Dysfunction Therapeutic Historic Market Size by Application (2020-2025)

5.2 Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Erectile Dysfunction Therapeutic Market Size (2020-2031)

6.2 North America Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025)

6.4 North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Erectile Dysfunction Therapeutic Market Size (2020-2031)

7.2 Europe Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025)

7.4 Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size (2020-2031)

8.2 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Erectile Dysfunction Therapeutic Market Size (2020-2031)

9.2 Latin America Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025)

9.4 Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size (2020-2031)

10.2 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Details

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Oral Erectile Dysfunction Therapeutic Introduction

11.1.4 Eli Lilly Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.1.5 Eli Lilly Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Oral Erectile Dysfunction Therapeutic Introduction

11.2.4 Pfizer Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Oral Erectile Dysfunction Therapeutic Introduction

11.3.4 Bayer Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.3.5 Bayer Recent Development

11.4 Teva Pharma

11.4.1 Teva Pharma Company Details

11.4.2 Teva Pharma Business Overview

11.4.3 Teva Pharma Oral Erectile Dysfunction Therapeutic Introduction

11.4.4 Teva Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.4.5 Teva Pharma Recent Development

11.5 S.K. Chemicals

11.5.1 S.K. Chemicals Company Details

11.5.2 S.K. Chemicals Business Overview

11.5.3 S.K. Chemicals Oral Erectile Dysfunction Therapeutic Introduction

11.5.4 S.K. Chemicals Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.5.5 S.K. Chemicals Recent Development

11.6 Seoul Pharma

11.6.1 Seoul Pharma Company Details

11.6.2 Seoul Pharma Business Overview

11.6.3 Seoul Pharma Oral Erectile Dysfunction Therapeutic Introduction

11.6.4 Seoul Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.6.5 Seoul Pharma Recent Development

11.7 CSBIO.

11.7.1 CSBIO. Company Details

11.7.2 CSBIO. Business Overview

11.7.3 CSBIO. Oral Erectile Dysfunction Therapeutic Introduction

11.7.4 CSBIO. Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

11.7.5 CSBIO. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

Pfizer Inc

Bayer

Teva Pharma

S.K. Chemicals

Seoul Pharma

CSBIO

List of Tables

Table 1. Global Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Protein

Table 3. Key Players of Hormones

Table 4. Key Players of Other

Table 5. Global Oral Erectile Dysfunction Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oral Erectile Dysfunction Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Erectile Dysfunction Therapeutic Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oral Erectile Dysfunction Therapeutic Market Share by Region (2020-2025)

Table 9. Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oral Erectile Dysfunction Therapeutic Market Share by Region (2026-2031)

Table 11. Oral Erectile Dysfunction Therapeutic Market Trends

Table 12. Oral Erectile Dysfunction Therapeutic Market Drivers

Table 13. Oral Erectile Dysfunction Therapeutic Market Challenges

Table 14. Oral Erectile Dysfunction Therapeutic Market Restraints

Table 15. Global Oral Erectile Dysfunction Therapeutic Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oral Erectile Dysfunction Therapeutic Market Share by Players (2020-2025)

Table 17. Global Top Oral Erectile Dysfunction Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Erectile Dysfunction Therapeutic as of 2024)

Table 18. Ranking of Global Top Oral Erectile Dysfunction Therapeutic Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oral Erectile Dysfunction Therapeutic Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oral Erectile Dysfunction Therapeutic, Headquarters and Area Served

Table 21. Global Key Players of Oral Erectile Dysfunction Therapeutic, Product and Application

Table 22. Global Key Players of Oral Erectile Dysfunction Therapeutic, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oral Erectile Dysfunction Therapeutic Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Type (2020-2025)

Table 26. Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Type (2026-2031)

Table 28. Global Oral Erectile Dysfunction Therapeutic Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Application (2020-2025)

Table 30. Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Application (2026-2031)

Table 32. North America Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 47. Eli Lilly Company Details

Table 48. Eli Lilly Business Overview

Table 49. Eli Lilly Oral Erectile Dysfunction Therapeutic Product

Table 50. Eli Lilly Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 51. Eli Lilly Recent Development

Table 52. Pfizer Company Details

Table 53. Pfizer Business Overview

Table 54. Pfizer Oral Erectile Dysfunction Therapeutic Product

Table 55. Pfizer Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 56. Pfizer Recent Development

Table 57. Bayer Company Details

Table 58. Bayer Business Overview

Table 59. Bayer Oral Erectile Dysfunction Therapeutic Product

Table 60. Bayer Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 61. Bayer Recent Development

Table 62. Teva Pharma Company Details

Table 63. Teva Pharma Business Overview

Table 64. Teva Pharma Oral Erectile Dysfunction Therapeutic Product

Table 65. Teva Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 66. Teva Pharma Recent Development

Table 67. S.K. Chemicals Company Details

Table 68. S.K. Chemicals Business Overview

Table 69. S.K. Chemicals Oral Erectile Dysfunction Therapeutic Product

Table 70. S.K. Chemicals Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 71. S.K. Chemicals Recent Development

Table 72. Seoul Pharma Company Details

Table 73. Seoul Pharma Business Overview

Table 74. Seoul Pharma Oral Erectile Dysfunction Therapeutic Product

Table 75. Seoul Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 76. Seoul Pharma Recent Development

Table 77. CSBIO. Company Details

Table 78. CSBIO. Business Overview

Table 79. CSBIO. Oral Erectile Dysfunction Therapeutic Product

Table 80. CSBIO. Revenue in Oral Erectile Dysfunction Therapeutic Business (2020-2025) & (US$ Million)

Table 81. CSBIO. Recent Development

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

Table 85. Authors List of This Report

List of Figures

Figure 1. Oral Erectile Dysfunction Therapeutic Picture

Figure 2. Global Oral Erectile Dysfunction Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Erectile Dysfunction Therapeutic Market Share by Type: 2024 VS 2031

Figure 4. Protein Features

Figure 5. Hormones Features

Figure 6. Other Features

Figure 7. Global Oral Erectile Dysfunction Therapeutic Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oral Erectile Dysfunction Therapeutic Market Share by Application: 2024 VS 2031

Figure 9. Age <20 Case Studies

Figure 10. Age 20-30 Case Studies

Figure 11. Age 31-40 Case Studies

Figure 12. Age 41-50 Case Studies

Figure 13. Age >50 Case Studies

Figure 14. Oral Erectile Dysfunction Therapeutic Report Years Considered

Figure 15. Global Oral Erectile Dysfunction Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Oral Erectile Dysfunction Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Oral Erectile Dysfunction Therapeutic Market Share by Region: 2024 VS 2031

Figure 18. Global Oral Erectile Dysfunction Therapeutic Market Share by Players in 2024

Figure 19. Global Top Oral Erectile Dysfunction Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Erectile Dysfunction Therapeutic as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Oral Erectile Dysfunction Therapeutic Revenue in 2024

Figure 21. North America Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Oral Erectile Dysfunction Therapeutic Market Share by Country (2020-2031)

Figure 23. United States Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Oral Erectile Dysfunction Therapeutic Market Share by Country (2020-2031)

Figure 27. Germany Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Share by Region (2020-2031)

Figure 35. China Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Oral Erectile Dysfunction Therapeutic Market Share by Country (2020-2031)

Figure 43. Mexico Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Share by Country (2020-2031)

Figure 47. Turkey Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Oral Erectile Dysfunction Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Eli Lilly Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 52. Bayer Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 53. Teva Pharma Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 54. S.K. Chemicals Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 55. Seoul Pharma Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 56. CSBIO. Revenue Growth Rate in Oral Erectile Dysfunction Therapeutic Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global ED Treatment Market Insights Forecast to 2030

Global Erectile Dysfunction Market Research Report 2025

Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030

Global Erectile Dysfunction Treatment Market Insights Forecast to 2030

Erectile Dysfunction ED Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Medications for Erectile Dysfunction Market Research Report 2024

Global Female Sexual Dysfunction Treatment Drug Market Research Report 2024

Global Female Sexual Dysfunction Treatment Market Insights Forecast to 2030

Global Erectile Dysfunction Devices Market Research Report 2024

Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tadalafil Oral Market Insights Forecast to 2030

Global Penile Implants or Penile Prosthesis Market Research Report 2024

Erectile Dysfunction ESWT Units Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Erectile Dysfunction Shockwave Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti erectile Dysfunction ED Drugs Market Insights Forecast to 2030

Global Vardenafil Market Insights Forecast to 2030

Global Drugs for Sexual Dysfunction Market Research Report 2024

Global Erectile Dysfunction Medicine Market Research Report 2024

Global Erectile Dysfunction Oral Medications Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions